Volume 3, Issue 3 (Aug 2018)
JNFS 2018, 3(3): 157-166 |
Back to browse issues page
Sahar Kermanian * 
, Hassan Mozaffari-Khosravi , Ghasem Dastgerdi , Javad Zavar-Reza , Masoud Rahmanian
, Hassan Mozaffari-Khosravi , Ghasem Dastgerdi , Javad Zavar-Reza , Masoud Rahmanian
Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract: (3745 Views)
Background: According to traditional beliefs, chamomile products have anti-depression effect. The aim of this study was to investigate the effects of chamomile tea on glycemic control, depression status and lipid profiles in type 2 diabetes (T2D) with depression. Methods: This randomized clinical trial was carried out on 74 depressed patients with T2D. Participants were randomly divided into two 37-people groups, chamomile tea (CG) and black tea group (BG). The CG received 3 cups of chamomile tea daily and the BG received 3 cups of black tea daily half an hour after meals for 12 weeks. To examine the status of depression, Beck II test was utilized. Anthropometric measurements, 24-h dietary recalls, glycosylated hemoglobin A1c (HbA1c) and blood lipids profile were measured at the baseline and at the end of the intervention. Results: The HbA1c mean was significantly reduced in CG after the intervention, when compared with BG (7.15 ± 1.23% vs. 7.98 ± 1.76%, P = 0.02). In the same vein, the mean changes in CG and BG were -0.74 ± 1.29 and 0.04 ± 1.07 (P = 0.006), respectively. No significant changes were observed in mean of serum lipids within and between groups. The Beck score also showed a significant reduction in the CG after the intervention (P < 0.001) and also, the mean changes showed a significant difference between the two groups. Conclusions: The results of this study demonstrated that drinking three cups of chamomile tea daily for 12 weeks by T2D suffering from depression lead to improve glycemic control and depression state. Therefore, drinking this kind of tea by these patients is recommended
Type of article: orginal article |
Subject:
public specific
Received: 2017/04/8 | Published: 2018/08/1 | ePublished: 2018/08/1
Received: 2017/04/8 | Published: 2018/08/1 | ePublished: 2018/08/1
References
1. Al-Jubouri H, Al-Jalil B, Farid I, Jasim F & Wehbi S 1990. The Effect of Chamomile on Hyperlipidemias in Rats. Journal of the faculty of medicine (Baghdad). 32 (1): 5-11.
2. Ali S, Stone MA, Peters JL, Davies MJ & Khunti K 2006. The Prevalence of Co-morbid Depression in Adults with Type 2 Diabetes: A Systematic Review and Meta-analysis. Diabeict medicine. 23 (11): 1165-1173.
3. Amsterdam JD, et al. 2012. Chamomile (Matricaria recutita) May Provide Antidepressant Activity in Anxious, Depressed Humans: An Exploratory Study. Alternative therapies in health and medicine. 18 (5): 44-49.
4. Anjaneyulu M, Chopra K & Kaur I 2003. Antidepressant Activity of Quercetin, A Bioflavonoid, in Streptozotocin-induced Ddiabetic Mice. Journal of medicinal food. 6 (4): 391-395.
5. Avallone R, et al. 2000. Pharmacological Profile of Apigenin, A Flavonoid Isolated from Matricaria Chamomilla. Biochemical pharmacology. 59 (11): 1387-1394.
6. Blumenthal M, Goldberg A & Brinckmann J 2000. Herbal Medicine. Expanded Commission E Monographs. Annals of internal medicine. 133 (6): 487-499.
7. Cemek M, Kaga S, Simsek N, Buyukokuroglu ME & Konuk M 2008. Antihyperglycemic and Antioxidative Potential of Matricaria Chamomilla L. in Streptozotocin-induced Diabetic Rats. Journal of natural medicines. 62 (3): 284-293.
8. Chang SM & Chen CH 2015. Effects of An Intervention with Drinking Chamomile Tea on Sleep Quality and Depression in Sleep Disturbed Postnatal Women: A Randomized Controlled Trial. Journal of advanced nursing. 72 (2): 306-315.
9. Dabson KS & Mohammad KP 2007. Psychometric Characteristics of Beck Depression Inventory-II in Patients with Major Depressive Disorder. Journal of rehabilitation 8(29): 82-88.
10. Darvishpadok MA, Namjoyan F, Khodayar M, Ahmadpour F & M Panahi A 2012. Effect of Matricaria Chamomilla L. on Blood Glucose and Glycosylated Hemoglobin in Female Fertile Diabetic Rats. Research in pharmaceutical sciences. 7 (5): S19-527.
11. Eddouks M, Lemhadri A, Zeggwagh NA & Michel JB 2005. Potent Hypoglycaemic Activity of The Aqueous Extract of Chamaemelum Nobile in Normal and Streptozotocin-induced Diabetic Rats. Diabetes research and clinical practice. 67 (3): 189-195.
12. Friedewald WT, Levy RI & Fredrickson DS 1972. Estimation of The Concentration of Low-density Lipoprotein Cholesterol in Plasma, Without Use of The Preparative Ultracentrifuge. Clinical chemistry. 18 (6): 499-502.
13. Guariguata L WD, Hambleton I, Beagley J, Linnenkamp U, Shaw J. 2014. Global Estimates of Diabetes Prevalence For 2013 and Projections for 2035. . Diabetes research and clinical practice. 103 (2): 137-149.
14. Kato A, et al. 2008. Protective Effects of Dietary Chamomile Tea on Diabetic Complications. Journal of agricultural and food chemistry. 56 (17): 8206-8211.
15. Khan SS, Najam R, Anser H, Riaz B & Alam N 2014. Chamomile tea: Herbal Hypoglycemic Alternative for Conventional Medicine. Pakistan journal of pharmaceutical sciences. 27 (5 Spec No): 1509-1514.
16. Kolodziejczyk-Czepas J, et al. 2015. Radical Scavenging and Antioxidant Effects of Matricaria Chamomilla Polyphenolic-Polysaccharide Conjugates. International journal of biological macromolecules. 72: 1152-1158.
17. Lee K-g & Shibamoto T 2002. Determination of Antioxidant Potential of Volatile Extracts Isolated From Various Herbs and Spices. Journal of agricultural and food chemistry. 50 (17): 4947-4952.
18. Lind M, et al. 2012. The Relationship between Glycaemic Control and Heart Failure in 83,021 Patients with Type 2 Diabetes. Diabetologia. 55 (11): 2946-2953.
19. Liu XH, Li XM, Han CC, Fang XF & Ma L 2015. Effects of Combined Therapy with Glipizide and Aralia Root Bark Extract on Glycemic Control and Lipid Profiles in Patients with Type 2 Diabetes Mellitus. Journal of the science of food and agriculture. 95 (4): 739-744.
20. Najla O, Olfat A, Kholoud S, Enas N & SA IH 2012. Hypoglycemic and Biochemical Effects of Matricaria Chamomilla Leave Extract in Streptozotocin-induced Diabetic Rats. Journal of health sciences. 2 (5): 43-48.
21. Nolte MS & Karam JH 2004. Pancreatic hormones and antidiabetic drugs. Basic and clinical pharmacology. 9th ed. New York: McGraw Hill Companies. 708.
22. Petronilho S, Maraschin M, Coimbra MA & Rocha SM 2012. In Vitro and In Vivo Studies of Natural Products: A Challenge for Their Valuation. The Case study of Chamomile (Matricaria recutita L.). Industrial crops and products. 40: 1-12.
23. Rafraf M, Zemestani M & Asghari-Jafarabadi M 2014. Effectiveness of Chamomile Tea on Glycemic Control and Serum Lipid Profile in Patients with Type 2 Diabetes. Journal of endocrinological investigation. 38 (2): 163-170.
24. Ramadan KS & Emam MA 2012. Biochemical Evaluation of Antihyperglycemic and Antioxidative Effects of Matricaria Chamomilla Leave Extract Studied in Streptozotocin-Induced Diabetic Rats. International journal research managment technology. 2: 298-302.
25. Shoara R, et al. 2015. Efficacy and Safety of Topical Matricaria Chamomilla L. (chamomile) Oil for Knee Asteoarthritis: A Randomized Controlled Clinical Trial. Complementary therapies in clinical practice. 21 (3): 181-187.
26. Srivastava JK & Gupta S 2011. Health Promoting Benefits of Chamomile in The Elderly Population. In Complementary and Alternative Therapies in The Aging Population, p. 135. Academic press.
27. Wang X, et al. 2014. Effects of Green Tea orGgreen Tea Extract on InsulinSsensitivity and Glycaemic Control in Populations at Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta‐analysis of Randomised Controlled Trials. Journal of human nutrition and dietetics. 27 (5): 501-512.
28. Weidner C, et al. 2013. Antidiabetic Effects of Chamomile Flowers Extract in Obese Mice through Transcriptional Stimulation of Nutrient Sensors of The Peroxisome Proliferator-activated Receptor (PPAR) family. PLoS One. 8 (11): e80335.
29. Yeghiazaryan K, Schild HH & Golubnitschaja O 2012. Chromium-picolinate Therapy in Diabetes Care: Individual Outcomes Require New Guidelines and Navigation by Predictive Diagnostics. Infectious disorders drug targets. 12 (5): 332-339.
30. Zemestani M, Rafraf M & Asghari-Jafarabadi M 2015. Chamomile Tea Improves Glycemic Indices and Antioxidants Status in Patients with Type 2 Diabetes Mellitus. Nutrition. 14 (15): 00328-00327.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |